Burjeel Holdings, a leading super-specialty healthcare provider in MENA and listed on the Abu Dhabi Securities Exchange, has announced that its board has authorised management to assess a potential share buyback of up to 10% of the group’s share capital. The programme is subject to approval from shareholders and the Securities and Commodities Authority.
The company stated that this decision reflects the board’s confidence in Burjeel Holdings’ long-term growth potential.
Strategic Rationale & Growth Outlook
The buyback initiative aligns with Burjeel Holdings’ strategy to optimise its capital structure and enhance shareholder value. The group expects mid-teens revenue growth and EBITDA margin expansion from 2025 onwards, driven by scaling high-growth assets, expanding complex medical procedures, and improving cost efficiencies. As a result, profit before tax is projected to increase at a compound annual growth rate of approximately 25% over the next four years.
To strengthen its leadership in healthcare, Burjeel Holdings continues to invest in advanced medical technologies, expand its specialty services, and enhance patient care. The group remains committed to improving operational efficiency, broadening service offerings, and leveraging digital transformation to maximise long-term stakeholder value.
Buyback Programme Details
The buyback will be executed through open market purchases and fully funded by operating cash flow, demonstrating the group’s strong financial position. Following the repurchase, management is considering various options, including resale based on market conditions, allocation to long-term incentive plans, or other regulator-approved strategies supporting capital management objectives, it said.
John Sunil, Group CEO of Burjeel Holdings, said: ” Burjeel Holdings is well-positioned to achieve its ambitious growth targets, in line with the strategic guidance provided to the market. With our strong operational performance and favorable market trends, we believe the Group’s intrinsic value is not yet fully reflected in its current market valuation. Recognising this opportunity, we proactively sought Board approval to explore a share buyback initiative. With this mandate secured, we will work closely with regulators and shareholders to finalise the buyback program and ensure timely market updates upon receiving the necessary approvals.”
